ROCCUZZO, GABRIELE
ROCCUZZO, GABRIELE
SCIENZE MEDICHE
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study
2022-01-01 Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P.
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome
2022-01-01 Cavallo F.; Roccuzzo G.; Merli M.; Avallone G.; Zocchi L.; Ogliara P.; Pasini B.; Quaglino P.; Ribero S.
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials
2021-01-01 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
2022-01-01 Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M.
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022-01-01 Fava P.; Roccuzzo G.; Alberti-Violetti S.; Grandi V.; Pileri A.; Pimpinelli N.; Berti E.; Quaglino P.
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents
2022-01-01 Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
2023-01-01 Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
2022-01-01 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice
2022-01-01 Roccuzzo, Gabriele; Mastorino, Luca; Gallo, Giuseppe; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association
2022-01-01 Roccuzzo G.; Cavallo F.; Avallone G.; Fava P.; Conti L.; Ribero S.; Fierro M.T.; Quaglino P.
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey
2023-01-01 Quaglino, Pietro; Scarisbrick, Julia; Roccuzzo, Gabriele; Abeldano, Alejandra; Battistella, Maxime; McCormack, Chris; Cowan, Richard; Cozzio, Antonio; Cury-Martins, Jade; Enz, Paula; Geskin, Larisa; Guenova, Emmanuella; Kim, Youn H; Knobler, Robert; Litvinov, Ivan V; Miyagaki, Tomomitsu; Molgo, Montserrat; Nicolay, Jan; Papadavid, Evangelina; Pinter-Brown, Lauren; Pujol Vallverdu, Ramon; Querfeld, Christiane; Ortiz-Romero, Pablo; Stadler, Rudolf; Vermeer, Maarten H; Bagot, Martine; Hodak, Emmilia
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
2021-01-01 Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P.
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks
2022-01-01 Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
2023-01-01 Avallone, Gianluca; Maronese, Carlo Alberto; Murgia, Giulia; Carrera, Carlo Giovanni; Mastorino, Luca; Roccuzzo, Gabriele; Dapavo, Paolo; Alberti-Violetti, Silvia; Quaglino, Pietro; Ribero, Simone; Marzano, Angelo Valerio
Maculopapular rash: An overlooked monkeypox diagnostic clue?
2022-01-01 Avallone, Gianluca; Maronese, Carlo Alberto; Quattri, Eleonora; Roccuzzo, Gabriele; Mastorino, Luca; Alberti-Violetti, Silvia; Ramoni, Stefano; Lucchini, Anna; Delmonte, Sergio; Quaglino, Pietro; Marzano, Angelo Valerio; Ribero, Simone
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies
2023-01-01 Roccuzzo, Gabriele; Moirano, Giovenale; Fava, Paolo; Maule, Milena; Ribero, Simone; Quaglino, Pietro
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population
2022-01-01 Mastorino L.; Roccuzzo G.; Dapavo P.; Siliquini N.; Avallone G.; Rubatto M.; Merli M.; Agostini A.; Ribero S.; Quaglino P.
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis
2022-01-01 Avallone G.; Cariti C.; Dapavo P.; Ortoncelli M.; Conforto L.; Mastorino L.; Roccuzzo G.; Cavallo F.; Rubatto M.; Quaglino P.; Ribero S.
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
2022-01-01 Avallone, Gianluca; Maronese, Carlo Alberto; Conforti, Claudio; Fava, Paolo; Gargiulo, Luigi; Marzano, Angelo Valerio; Massone, Cesare; Mastorino, Luca; Paradisi, Andrea; Pileri, Alessandro; Quaglino, Pietro; Rizzo, Nathalie; Ribero, Simone; Roccuzzo, Gabriele; Tavoletti, Gianluca; Vignoli, Carlo Alberto; Zalaudek, Iris; Berti, Emilio; Alberti-Violetti, Silvia
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient
2023-01-01 Avallone, Gianluca; Dapavo, Paolo; Cabutti, Francesco; Preti, Mario; Cavallo, Francesco; Roccuzzo, Gabriele; Mastorino, Luca; Rubatto, Marco; Quaglino, Pietro; Ribero, Simone
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study | 2022 | Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P. | |
| BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome | 2022 | Cavallo F.; Roccuzzo G.; Merli M.; Avallone G.; Zocchi L.; Ogliara P.; Pasini B.; Quaglino P.; Ribero S. | |
| Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. | |
| Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma | 2022 | Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M. | |
| Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management | 2022 | Fava P.; Roccuzzo G.; Alberti-Violetti S.; Grandi V.; Pileri A.; Pimpinelli N.; Berti E.; Quaglino P. | |
| Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents | 2022 | Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone | |
| Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study | 2023 | Repetto, Federica; Roccuzzo, Gabriele; Burzi, Lorenza; Mastorino, Luca; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone | |
| Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? | 2022 | Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice | 2022 | Roccuzzo, Gabriele; Mastorino, Luca; Gallo, Giuseppe; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association | 2022 | Roccuzzo G.; Cavallo F.; Avallone G.; Fava P.; Conti L.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey | 2023 | Quaglino, Pietro; Scarisbrick, Julia; Roccuzzo, Gabriele; Abeldano, Alejandra; Battistella, Maxime; McCormack, Chris; Cowan, Richard; Cozzio, Antonio; Cury-Martins, Jade; Enz, Paula; Geskin, Larisa; Guenova, Emmanuella; Kim, Youn H; Knobler, Robert; Litvinov, Ivan V; Miyagaki, Tomomitsu; Molgo, Montserrat; Nicolay, Jan; Papadavid, Evangelina; Pinter-Brown, Lauren; Pujol Vallverdu, Ramon; Querfeld, Christiane; Ortiz-Romero, Pablo; Stadler, Rudolf; Vermeer, Maarten H; Bagot, Martine; Hodak, Emmilia | |
| Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives | 2021 | Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks | 2022 | Mastorino, L; Cantafio Duò, V L; Vecco, C; Gelato, F; Giordano, S; Roccuzzo, G; Cavaliere, G; Avallone, G; Ortoncelli, M; Ribero, S; Quaglino, P | |
| Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study | 2023 | Avallone, Gianluca; Maronese, Carlo Alberto; Murgia, Giulia; Carrera, Carlo Giovanni; Mastorino, Luca; Roccuzzo, Gabriele; Dapavo, Paolo; Alberti-Violetti, Silvia; Quaglino, Pietro; Ribero, Simone; Marzano, Angelo Valerio | |
| Maculopapular rash: An overlooked monkeypox diagnostic clue? | 2022 | Avallone, Gianluca; Maronese, Carlo Alberto; Quattri, Eleonora; Roccuzzo, Gabriele; Mastorino, Luca; Alberti-Violetti, Silvia; Ramoni, Stefano; Lucchini, Anna; Delmonte, Sergio; Quaglino, Pietro; Marzano, Angelo Valerio; Ribero, Simone | |
| Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies | 2023 | Roccuzzo, Gabriele; Moirano, Giovenale; Fava, Paolo; Maule, Milena; Ribero, Simone; Quaglino, Pietro | |
| Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population | 2022 | Mastorino L.; Roccuzzo G.; Dapavo P.; Siliquini N.; Avallone G.; Rubatto M.; Merli M.; Agostini A.; Ribero S.; Quaglino P. | |
| Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis | 2022 | Avallone G.; Cariti C.; Dapavo P.; Ortoncelli M.; Conforto L.; Mastorino L.; Roccuzzo G.; Cavallo F.; Rubatto M.; Quaglino P.; Ribero S. | |
| Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals | 2022 | Avallone, Gianluca; Maronese, Carlo Alberto; Conforti, Claudio; Fava, Paolo; Gargiulo, Luigi; Marzano, Angelo Valerio; Massone, Cesare; Mastorino, Luca; Paradisi, Andrea; Pileri, Alessandro; Quaglino, Pietro; Rizzo, Nathalie; Ribero, Simone; Roccuzzo, Gabriele; Tavoletti, Gianluca; Vignoli, Carlo Alberto; Zalaudek, Iris; Berti, Emilio; Alberti-Violetti, Silvia | |
| Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient | 2023 | Avallone, Gianluca; Dapavo, Paolo; Cabutti, Francesco; Preti, Mario; Cavallo, Francesco; Roccuzzo, Gabriele; Mastorino, Luca; Rubatto, Marco; Quaglino, Pietro; Ribero, Simone |